1 / 26

Judita Kinkorová 23. května 2013, Větruše, Ústí na Labem

"Horizon 2020 - the Framework Programme for Research and Innovation„ Health, demographic change and wellbeing. Judita Kinkorová 23. května 2013, Větruše, Ústí na Labem. HORIZON 2020/ structure. 1 Excellent science 2 Industrial leadership 3 Societal challenges FP7. Cooperation. Ideas.

vienna
Download Presentation

Judita Kinkorová 23. května 2013, Větruše, Ústí na Labem

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. "Horizon 2020 - the Framework Programme for Research and Innovation„Health, demographic change and wellbeing Judita Kinkorová 23. května 2013, Větruše, Ústí na Labem

  2. HORIZON 2020/ structure • 1 Excellent science2 Industrial leadership3 Societal challenges • FP7 Cooperation Ideas People Capacities

  3. Novinky H 2020 • € 80.2 Billion marked in the Commission proposals for 2014-2020 EU budget • (June 2011) • Covering current funding for: • • The 7th Framework Programme (FP7) for research, technological development • and demonstration • – €53 billion (2007-13). 4 main programmes on Ideas, Cooperation, People and Capacities. • • The Competitiveness and Innovation Framework Programme (CIP) • – €3.6 billion (2007-13). 3 programmes on enterprise & innovation, intelligent energy, and ICT • policy support. • • The European Institute for Innovation and Technology (EIT) • – Autonomous EU body bringing together higher education, research and business to • stimulate innovation in Knowledge and Innovation Communities. EU budget contribution of • €309 million (2007-13) • And strengthening complementarities with the Structural Funds • – €86 billion allocated

  4. Excellent scienceProposed funding (million euro, 2014-20) Cooperation Ideas • European Research Council • Frontier research by the best individual teams13 268 • Future and Emerging Technologies • Collaborative research to open new fields of innovation3 100 • Marie Curie actions • Opportunities for training and career development5 572 • Research infrastructures (including e-infrastructure) • Ensuring access to world-class facilities2 478 People Capacities

  5. Industrial leadershipProposed funding (million euro, 2014-20) • Leadership in enabling and industrial technologies (ICT, nanotechnologies, materials, biotechnology, manufacturing, space)13 781 • Access to risk finance Leveraging private finance and venture capital for research and innovation3 538 • Innovation in SMEs Fostering all forms of innovation in all types of SMEs619

  6. HORIZON 2020Societal challengesProposed funding (million euro, 2014-20) • Health, demographic change and wellbeing8 033 • Food security, sustainable agriculture, marine and maritime research & the bioeconomy4 152 • Secure, clean and efficient energy*5 782 • Smart, green and integrated transport6 802 • Climate action, resource efficiency and raw materials3 160 • Inclusive, innovative and secure societies3 819

  7. HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEINGMain Specific Challenges Considered • 1. Prevention • Better understanding and management of the relationship between environment, behaviour, nutrition, genetics and their contribution to health and disease. • Facilitating active and healthy ageing, and theprevention, delay and attenuation of diseaseand disability with tools and services including those supporting self care.

  8. HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEINGMain Specific Challenges Considered • 2. Combating and curing disease • Better understanding the mechanisms of disease and redefining their taxonomies • Better understanding of the normal processes of human growth and development • Promoting conditions favouring drug discovery anddevelopment (through public private partnerships) • The development and validation of innovative therapies,medical technologies, and vaccines and diagnostics

  9. PPP –Innovative Medicines Initiative

  10. HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEINGMain Specific Challenges Considered • 3. Increasing the sustainability and efficiency of the health and social care sector • Research in health systems, investment in capacitybuilding, exchange of information between nationalsystems, technology and quality assessments,investigation of health interventions, the socioeconomicimpacts of health and disease. • Assistive and independent living solutions, ethics, serviceinnovation, and societal uptake of innovation. • Enhancing preparedness for emerging epidemics andotheremerginghealththreats.

  11. HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING /1/Overarching features considered: • Provision for the long-term study of well characterised, largepopulations; data collection and processing. • Development of and support for both biological and datainfastructures (bio-banks, cohorts, animal models, etc.) and for other medical research facilities and infrastructures. • Support for the development of tools and technologies including –omics, high throughput research, systems biology and imaging, and for research using these.

  12. HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING /2/Overarching features considered: • Support for regulatory sciences (drug safety, clinical trials,cell & gene therapies, specialist manufacturing, etc.) • Support for converting knowledge into innovation, for theimprovement of clinical practice and the development ofmarketableproducts and services.

  13. HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEINGInternational co-operation: Major strategic international initiatives to be pursued, including: • Be a leader in large worldwide research consortia • EDCTP-2, Rare Diseases (International Rare Diseases Research Consortium - IRDiRC), International Human Microbiome Consortium – IHMC, International Initiative for Traumatic Brain Injury Research – InTBIR, Trans-Atlantic Task Force on antimicrobial resistance – TATFAR, etc., to improve availability of interventions

  14. Tuesday, 14 May 2013 Brussels, BelgiumEuropean Brain Research Successes and Next Challenges • Monday, 27 May and Tuesday, 28 May 2013 Dublin, IrelandHealthy brain: healthy Europe – A new horizon for brain research and health care

  15. OTHER EU ACTIVITIES/1Joint Programming Initiative • What is the Joint Programming Initiative (JPI)? • Research efforts can be essential to address major societal challenges. In some cases these are so great that national research programmes cannot tackle them effectively on their own. Yet, the vast bulk of research programmes in Europe are run in an isolated way, leading to unwanted fragmentation or ineffectiveness. Joint programming aims to remedy this situation. • Neurodegenerative Diseases (NDJP) • Healthy Diet for Healthy Life (JPI HDHL) • More Years Better Life (JPI MYBL) • Antimicrobial Resistance (JPI AMR)

  16. OTHER EU ACTIVITIES/2European Innovation PartneshipActive and Healthy Living • European Innovation Partnerships (EIPs) are a new approach to EU research and innovation.EIPs are challenge-driven, focusing on societal benefits and a rapid modernisation of the associated sectors and markets. • EIPs streamline, simplify and better coordinate existing instruments and initiatives and complement them with new actions where necessary. This should make it easier for partners to co-operate and achieve better and faster results compared to what exists already. Therefore, they build upon relevant existing tools and actions and, where this makes sense, they integrate them into a single coherent policy framework. Flexibility is important; there is not a 'one-size-fits-all' framework.

  17. OTHER EU ACTIVITIES/3Knowledge and Innovation Communities(KICs)

  18. What are European Institute of Innovation & Technology andKnowledge and Innovation Communities (KICs)? • EIT = highly integrated, creative and excellence-driven partnershipwhich brings together the fields of education, technology, research, business and entrepreneurship, in order to produce new innovations and new innovation models that inspire others to emulate it. They are to become key drivers of sustainable economic growth and competitiveness across Europe through world-leading innovation. The KICs will be driving effective “translation” between partners in ideas, technology, culture, and business models, and will create new business for existing industry and for new endeavours • KIC = independent but operational part of the EIT, which puts the innovation web into practice

  19. KIC model • High degree of integration world-class KIC partners from the knowledge triangle • Long term strategic approach – 7 years (minimum) • Autonomy and flexibility: org. structure and activities governed by a Board of KIC • Effective governance • Smart funding: EIT funding to KICs max. 25% • Co-location model: 5-6 world class innovation hotspot building • Results – high impact oriented activities: Business plan, results, impact

  20. The first three KICs and co-location centres

  21. EIT in Horizon 2020 WHY? alignment of priorities synergies knowledge triangle integration MAIN PRINCIPLES two waves of KICs (2014-2018) mid term review budget H2020 EIT 1.54 bn € 2014-2017 1.65 bn € 2018-2020

  22. Future KICs themes (proposed) • 1st wave: 2014 (tbc) • Innovation for healthy living and active ageing • Food4Future - sustainable supply chain from resources to consumers • Raw materials – sustainable exploration, extraction, processing and recycling • 2nd wave: 2018 (tbc) • Urban mobility • Added-value manufacturing • Smart secure societies

  23. The European Institute of Innovation and Technology: Fostering Innovation and Strengthening Synergies within the EU http://eitdublin.teamwork.fr/en/

  24. Malta - KIC • The Republic of Malta, through joint collaboration between several ministries and national entities is preparing to submit an application to participate in a “Knowledge and Innovation Community” (KIC) initiative. This initiative, which will be launched by the European Institute of Innovation and Technology in 2014, will have an investment volume of up to €1.6 billion. The lead institution for this application is Leuphana University of Lüneburg, Germany, which is working closely with Maltese stakeholders through the Malta Council for Science and Technology, to develop a proposal that addresses the societal challenge of a progressively ageing population in Europe and beyond. The Honourable Dr. Joseph Muscat, Prime Minister of Malta, has stated that “the Maltese government fully supports this Knowledge and Innovation Community initiative which is being spearheaded by Leuphana University, having as its local coordinating entity the Malta Council for Science and Technology”. • http://www.mcst.gov.mt/all/policy-strategy/internationalization-opportunities/eu1-6-billion-optimise-healthy-and-active

  25. Dear Dr Kinkorova, • Thank you for your message and all information, you've kindly sent me. • As declared before, we are open to any collaboration with the Czech groups/institutions in the field of KIC Health. The list of 4-5 leading partners seriously interested in the participation in the future CC would be welcome. The conditions to be accepted as KIC/CC partners are: • i) scientific excellence in the field of Health Sciences; • ii) personal and institutional collaborative potential; • iii) financial stability (to cover annual KIC/CC contribution in cash and in kind); •   At the moment we are organizing the meeting of the Polish partners and trying to keep in touch with potential Middle/Eastern European partners. • I'll inform you about new initiatives. • With best greetings from Krakow • Andrzej Adamski • Rector's Proxy for KICs and CCs • Andrzej Adamski, Ph.D. • Jagiellonian University • Faculty of Chemistry • Ingardena 3 • PL 30-060 Krakow

  26. Děkuji Vám za pozornost Judita Kinkorová HCP Health Technologické centrum AV ČR kinkorova@tc.cz • www.tc.cz

More Related